Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Olschowka

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Advances in Experimental Medicine and Biology|April 1, 2003
Selective inhibition of cyclooxygenase-2 attenuates expression of inflammation-related genes in CNS injuryM Kerry O'Banion, Stephanos Kyrkanides, John A Olschowka
Pharmaceutics|July 29, 2023
Inconsistent Effects of Glatiramer Acetate Treatment in the 5xFAD Mouse Model of Alzheimer's DiseaseBerke Karaahmet, John A Olschowka, M Kerry O'Banion
Journal of Neurotrauma|February 21, 2002
Cyclooxygenase inhibition as a strategy to ameliorate brain injurySean D Hurley, John A Olschowka, M Kerry O'Banion
Journal of Neuroimmunology|February 21, 2004
Intraparenchymal administration of interleukin-1beta induces cyclooxygenase-2-mediated expression of membrane- and cytosolic-associated prostaglandin E synthases in mouse brainAmy H Moore, John A Olschowka, M Kerry O'Banion
Frontiers in Immunology|December 6, 2014
Are "resting" microglia more "m2"?Jonathan D Cherry, John A Olschowka, M Kerry O'Banion
Journal of Neuroinflammation|June 4, 2014
Neuroinflammation and M2 microglia: the good, the bad, and the inflamedJonathan D Cherry, John A Olschowka, M Kerry O'Banion
Journal of Neuroinflammation|November 6, 2015
Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammationJonathan D Cherry, John A Olschowka, M Kerry O'Banion
Journal of Neuroinflammation|April 7, 2019
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's diseaseDawling A Dionisio-Santos, John A Olschowka, M Kerry O'Banion
Journal of Neuroinflammation|February 5, 2016
Brain radiation injury leads to a dose- and time-dependent recruitment of peripheral myeloid cells that depends on CCR2 signalingMichael J Moravan, John A Olschowka, Jacqueline P Williams, et al.
Frontiers in Neuroscience|June 13, 2020
Evaluating the Effect of Interleukin-4 in the 3xTg Mouse Model of Alzheimer's DiseaseDawling A Dionisio-Santos, Adib Behrouzi, John A Olschowka, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Advances in Experimental Medicine and Biology|April 1, 2003
Selective inhibition of cyclooxygenase-2 attenuates expression of inflammation-related genes in CNS injuryM Kerry O'Banion, Stephanos Kyrkanides, John A Olschowka
Pharmaceutics|July 29, 2023
Inconsistent Effects of Glatiramer Acetate Treatment in the 5xFAD Mouse Model of Alzheimer's DiseaseBerke Karaahmet, John A Olschowka, M Kerry O'Banion
Journal of Neurotrauma|February 21, 2002
Cyclooxygenase inhibition as a strategy to ameliorate brain injurySean D Hurley, John A Olschowka, M Kerry O'Banion
Journal of Neuroimmunology|February 21, 2004
Intraparenchymal administration of interleukin-1beta induces cyclooxygenase-2-mediated expression of membrane- and cytosolic-associated prostaglandin E synthases in mouse brainAmy H Moore, John A Olschowka, M Kerry O'Banion
Frontiers in Immunology|December 6, 2014
Are "resting" microglia more "m2"?Jonathan D Cherry, John A Olschowka, M Kerry O'Banion
Journal of Neuroinflammation|June 4, 2014
Neuroinflammation and M2 microglia: the good, the bad, and the inflamedJonathan D Cherry, John A Olschowka, M Kerry O'Banion
Journal of Neuroinflammation|November 6, 2015
Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammationJonathan D Cherry, John A Olschowka, M Kerry O'Banion
Journal of Neuroinflammation|April 7, 2019
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's diseaseDawling A Dionisio-Santos, John A Olschowka, M Kerry O'Banion
Journal of Neuroinflammation|February 5, 2016
Brain radiation injury leads to a dose- and time-dependent recruitment of peripheral myeloid cells that depends on CCR2 signalingMichael J Moravan, John A Olschowka, Jacqueline P Williams, et al.
Frontiers in Neuroscience|June 13, 2020
Evaluating the Effect of Interleukin-4 in the 3xTg Mouse Model of Alzheimer's DiseaseDawling A Dionisio-Santos, Adib Behrouzi, John A Olschowka, et al.
Pageof 6